Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andrew D. Feld is active.

Publication


Featured researches published by Andrew D. Feld.


Annals of Internal Medicine | 2008

National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults.

C. Seth Landefeld; Barbara J. Bowers; Andrew D. Feld; Katherine E Hartmann; Eileen Hoffman; Melvin J. Ingber; Joseph T. King; W. Scott McDougal; Heidi Nelson; Endel John Orav; Michael Pignone; Lisa Richardson; Robert M. Rohrbaugh; Hilary Siebens; Bruce J. Trock

The ramifications of fecal incontinence and urinary incontinence extend well beyond their physical manifestations. To promote work that will reduce suffering and costs attributable to fecal and uri...


The American Journal of Gastroenterology | 2000

Intergenerational transmission of gastrointestinal illness behavior

Rona L. Levy; William E. Whitehead; Michael Von Korff; Andrew D. Feld

Abstract OBJECTIVE: Previous research, based on retrospective reporting, suggests that parental reinforcement and modeling may be important mechanisms in the development of gastrointestinal illness behavior in children and adults. The aim of this study was to determine the relationship between the illness behavior of parents, in the form of health care use for irritable bowel symptoms, and the illness behavior of their children, without relying on retrospective recall. METHODS: A comparison of two matched groups was made. Groups included 631 children of parents who were diagnosed with irritable bowel syndrome during 1 calendar yr and 646 children of parents matched by parental age, gender, and number of children in the family who did not receive an IBS diagnosis during the same 1 yr. Health care use and costs over a 3-yr calendar period for all children and their parents collected from the health care database of a large health maintenance organization were evaluated. RESULTS: Case children had significantly more ambulatory care visits for all causes (mean 12.26 vs 9.81, p = 0.0001) and more ambulatory visits for gastrointestinal symptoms (0.35 vs 0.18, p = 0.0001). Outpatient health care costs over the 3-yr period were also significantly higher for case than control children (


The American Journal of Gastroenterology | 2004

Increased Somatic Complaints and Health-Care Utilization in Children: Effects of Parent IBS Status and Parent Response to Gastrointestinal Symptoms

Rona L. Levy; William E. Whitehead; Lynn Walker; Michael Von Korff; Andrew D. Feld; Michelle D. Garner; Dennis L. Christie

1979 vs


The American Journal of Gastroenterology | 2001

Costs of care for irritable bowel syndrome Patients in a health maintenance organization

Rona L. Levy; Michael Von Korff; William E. Whitehead; Paul E. Stang; Kathleen Saunders; Priti Jhingran; Victoria Barghout; Andrew D. Feld

1546, p = 0.0001). Controlling for the total number of ambulatory visits of the parents, excluding gastrointestinal visits, did not alter the findings. Gender of the IBS parent was not related to children’s gastrointestinal visits. CONCLUSION: This study extends previous research by showing that specific types of illness behavior may be learned through modeling.


Alimentary Pharmacology & Therapeutics | 2007

Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain

K. A. Nyrop; Olafur S. Palsson; Rona L. Levy; M. Von Korff; Andrew D. Feld; Marsha J. Turner; William E. Whitehead

OBJECTIVES:Irritable bowel syndrome (IBS) runs in families. The aims of this study were (i) to exclude biased perception by a mother with irritable bowel as the explanation for increased gastrointestinal (GI) symptoms in their children, (ii) to determine whether non-GI as well as GI symptoms run in families, and (iii) to determine whether parent IBS status and solicitous responses to illness exert independent effects on childrens symptom reports, medical clinic visits, and school absences.METHODS:Two hundred and eight mothers with irritable bowel and their 296 children (cases: average age 11.9 yr; 48.6% male) and 241 nonirritable bowel mothers and their 335 children (controls: 11.8 yr; 49.0% male) were interviewed. Other factors assessed were stress, mothers and childs psychological symptoms, childs perceived competence, pain coping style, age, and sex. Children were interviewed apart from their parents.RESULTS:Case children independently reported more frequent stomach aches (F(591) = 9.22; p= 0.0025) and non-GI symptoms (F(562) = 21.03; p < 0.001) than control children. Case children also had more school absences (F(625) = 26.53; p < 0.0001), physician visits for GI symptoms (F(602) = 8.09; p= 0.005), and non-GI clinic visits (F(602) = 27.92; p < 0.001) than control children. Children whose mothers made solicitous responses to illness complaints independently reported more severe stomach aches (F(590) = 11.42; p < 0.001), and they also had more school absences for stomach aches (F(625) = 5.33; p < 0.05), but solicitous behavior did not significantly impact non-GI symptom reporting, clinic visits, or school absences. Differences between cases and controls remained significant after adjusting for potential moderators.CONCLUSIONS:(i) Frequent GI complaints in children whose mothers have irritable bowel are not explained by the mothers biased perceptions; (ii) children of mothers with irritable bowel have more non-GI as well as GI symptoms, disability days, and clinical visits; (iii) and parent IBS status and solicitous responses to illness have independent effects on the childs symptom complaints.


The American Journal of Gastroenterology | 2007

Comorbidity in irritable bowel syndrome

William E. Whitehead; Olafur S. Palsson; Rona R. Levy; Andrew D. Feld; Marsha J. Turner; Michael Von Korff

Abstract OBJECTIVES: The aims of this study were: 1) to determine the total costs of care and costs related to lower GI–related problems for patients who received a diagnosis of irritable bowel syndrome (IBS), and 2) to compare them to age- and sex-matched population controls and patients treated for inflammatory bowel disease (IBD) or gastroesophageal reflux disease (GERD). METHODS: Use and cost data were obtained through the computerized information systems of a large staff-model health maintenance organization on three groups of patients diagnosed in 1994 or 1995 with IBS, IBD, or GERD; and an age- and sex-matched control group of patients without any of these listed diagnoses. The IBS patient group was compared to the three comparison groups on components of total and IBS-related costs. RESULTS: Total costs of care for IBS patients were 49% higher than population controls during the year starting with the visit at which IBS patients were identified. In the index year, every component of total costs except inpatient care was significantly higher for IBS patients than for population controls. The costs of care for lower GI problems were significantly higher for patients with IBS than for population controls across a range of services. However, only 33% of the difference in total costs of care between IBS patients and population controls was due to lower GI–related services in the index year. In the subsequent years, lower GI–related services accounted for 18% and 20% of the total cost difference between IBS patients and population controls. The total costs of care as well as the components of costs of care were generally higher for IBD patients than for IBS patients, but were comparable for GERD and IBS patients. CONCLUSIONS: Patients with IBS show sustained increases in health care costs relative to population controls for both lower GI services and care unrelated to lower GI problems. However, the majority of the excess in health care costs resulted from medical care not directly related to lower GI problems.


The American Journal of Gastroenterology | 2010

Inability of the Rome III Criteria to Distinguish Functional Constipation from Constipation Subtype Irritable Bowel Syndrome

Reuben K. Wong; Olafur S. Palsson; Marsha J. Turner; Rona L. Levy; Andrew D. Feld; Michael Von Korff; William E. Whitehead

Aim To provide estimates of actual costs to deliver health care to patients with functional bowel disorders, and to assess the cost impact of symptom severity, recency of onset, and satisfaction with treatment.


Digestive Diseases and Sciences | 2001

Autonomic Nervous System Function in Women with Irritable Bowel Syndrome

Monica Jarrett; Kevin C. Cain; Robert L. Burr; Rona L. Levy; Andrew D. Feld; Vicky Hertig

BACKGROUND:Comorbid nongastrointestinal symptoms account for two-thirds of excess health-care costs in irritable bowel syndrome (IBS).OBJECTIVES:To determine whether IBS patients are at greater risk for specific comorbid disorders versus showing a general tendency to overreport symptoms; whether patients with inflammatory bowel disease (IBD) show patterns of comorbidity similar to IBS; whether comorbidity is explained by psychiatric disease; and whether excess comorbidity occurs in all IBS patients.METHODS:All 3,153 patients in a health maintenance organization with a diagnosis of IBS in 1994–1995 were compared to 3,153 age- and gender-matched controls, and to 571 IBD patients. All diagnoses in a 4-yr period beginning 1 yr before their index visit were categorized as gastrointestinal, psychiatric, or nongastrointestinal somatic. Nongastrointestinal somatic diagnoses were further divided into symptom-based versus biological marker-based diagnoses.RESULTS:Forty-eight of 51 symptom-based and 16 of 25 biomarker-based diagnoses were significantly more common in IBS versus controls. However, there were no unique associations. Bacterial, viral, and fungal infections and stroke were among diagnoses made more frequently in IBS. IBD patients were similar to controls. Greater somatic comorbidity was associated with concurrent psychiatric diagnosis. Only 16% of IBS patients had abnormally high numbers of comorbid diagnoses.CONCLUSIONS:Comorbidity in IBS is due to a general amplification of symptom reporting and physician consultation rather than a few unique associations; this suggests biased symptom perception rather than shared pathophysiology. Comorbidity is influenced by, but is not explained by, psychiatric illness. Excess comorbidity is present in only a subset of IBS patients.


Clinical Gastroenterology and Hepatology | 2004

Self-Management for Women With Irritable Bowel Syndrome

Monica Jarrett; Rona L. Levy; Kevin C. Cain; Robert L. Burr; Andrew D. Feld; Pam Barney; Pam Weisman

OBJECTIVES:The Rome III classification system treats functional constipation (FC) and irritable bowel syndrome with constipation (IBS-C) as distinct disorders, but this distinction appears artificial, and the same drugs are used to treat both. This studys hypothesis is that FC and IBS-C defined by Rome III are not distinct entities.METHODS:In all, 1,100 adults with a primary care visit for constipation and 1,700 age- and gender-matched controls from a health maintenance organization completed surveys 12 months apart; 66.2% returned the first questionnaire. Rome III criteria identified 231 with FC and 201 with IBS-C. The second survey was completed by 195 of the FC and 141 of the IBS-C cohorts. Both surveys assessed the severity of constipation and IBS, quality of life (QOL), and psychological distress.RESULTS:(i) Overlap: if the Rome III requirement that patients meeting criteria for IBS cannot be diagnosed with FC is suspended, 89.5% of IBS-C cases meet criteria for FC and 43.8% of FC patients fulfill criteria for IBS-C. (ii) No qualitative differences between FC and IBS-C: 44.8% of FC patients report abdominal pain, and paradoxically IBS-C patients have more constipation symptoms than FC. (iii) Switching between diagnoses: by 12 months, 1/3 of FC transition to IBS-C and 1/3 of IBS-C change to FC.CONCLUSIONS:Patients identified by Rome III criteria for FC and IBS-C are not distinct groups. Revisions to the Rome III criteria, possibly including incorporation of physiological tests of transit and pelvic floor function, are needed.


BMC Complementary and Alternative Medicine | 2008

Complementary and alternative medicine use and cost in functional bowel disorders: A six month prospective study in a large HMO

Miranda A. van Tilburg; Olafur S. Palsson; Rona L. Levy; Andrew D. Feld; Marsha J. Turner; Douglas A. Drossman; William E. Whitehead

Autonomic nervous system (ANS) balance was assessed in women with and without irritable bowel syndrome (IBS) using laboratory tests of function (ie, expiratory/inspiratory ratio, Valsalva, posture changes, and cold pressor) and spectral and nonspectral measures of heart rate variability (HRV). Women with (N = 103) and without IBS (N = 49) were recruited, interviewed, then completed a laboratory assessment and wore a 24-hr Holter monitor Analysis using the entire sample showed little difference between IBS and control women and between subgroups with IBS on either laboratory measures or 24-hr HRV measures. However, analysis restricted to those women with severe IBS symptoms showed quite pronounced differences between two IBS subgroups on 24-hr HRV measures. Parasympathetic tone was significantly lower and ANS balance was significantly higher in the constipation-predominant compared to the diarrhea-predominant group. Subgroups of women with IBS do differ in ANS function as measured by 24-hr HRV; however, these differences are only apparent among women with severe symptoms. These findings point out the importance of considering symptom severity when interpreting studies of IBS.

Collaboration


Dive into the Andrew D. Feld's collaboration.

Top Co-Authors

Avatar

Rona L. Levy

University of Washington

View shared research outputs
Top Co-Authors

Avatar

William E. Whitehead

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Olafur S. Palsson

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marsha J. Turner

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

Ann G. Zauber

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Sidney J. Winawer

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge